Effects of Alpha Interferon Treatment on Intrinsic Anti-HIV-1 Immunity In Vivo

Supplemental material

Files in this Data Supplement:

• Supplemental file 1 -

  Table S1 (SHCS subject characteristics at baseline (pre-IFN-α/riba treatment).)

  Table S2 (SCOPE cohort subject characteristics.)

  Table S3 (List of the 34 anti-HIV-1 host restriction factors measured by our CuRe Array.)

  Table S4 (Fold changes and statistical comparisons between treatment states.)

  Fig. S1 (Example of quantitative PCR analysis strategy.)

  Fig. S2 (Effect of IFN-α/riba therapy on HIV-1 viral load in plasma.)

  Fig. S3 (Nine IFN-α/riba-induced genes that exhibited significant correlation between fold induction and HIV-1 viral load reduction during IFN-α/riba therapy.)

  Fig. S4 (Comparison of the nine IFN-α/riba-induced genes that exhibited significant correlation between fold induction and HIV-1 viral load reduction during IFN-α/riba therapy from SHCS subjects during IFN-α/riba therapy and HIV-1-negative and HIV-1-infected (ART-untreated) viremic individuals enrolled in the SCOPE cohort.)

  Supplementary references.

  PDF, 1.5M